InvestorsHub Logo
Followers 28
Posts 1444
Boards Moderated 0
Alias Born 12/18/2014

Re: flipper44 post# 417302

Monday, 11/15/2021 9:01:01 AM

Monday, November 15, 2021 9:01:01 AM

Post# of 729773
A couple of notes: Direct is partially automated and as we know it has been for a while. There is a lot of art inherently in living cell production. As an investor I would like to think NWBO also has some trade secret art relative to optimization. Automation is a good way to protect trade secret art if it can be incorporated into the firmware for production. That stated I like the revised patent language better than the original language for the claim on the maturation. As ex pointed out the original claim was denied my response to him is pasted below.

Knew the clarification was coming…..
The prosecution of Direct patent took some time, question of efficacy aside, the allowance of about 16 accomplishes the same thing as 12 to 20. Assuming that is key to the secret sauce……



Assuming there is value in this patent the fact that the prosecution took some time and the original claim was denied will likely signal that this patent is vulnerable and could be challenged and possibly invalidated in court. That stated in behooves NWBO to have all their ducks in a row and may explain the protracted delay in many areas.
As an aside there is a patent battle going on now between Moderna and and one of your favorite organizations the NIH over patents for the mRNA vaccine produced by Moderna. Which happens to be the most effective Covid vaccine to date. And an example of what happens when big $$$‘s are on the line.

Also hope our experience with Covid will in time help us get over our trepidation around mRNA vaccines. Because they are the future and at some point our flu vaccines will likely be mRNA vaccines.

Recovering former moderator.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News